Free shipping on all orders over $ 500

WYE-354

Cat. No. M1755

All AbMole products are for research use only, cannot be used for human consumption.

WYE-354 Structure
Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
2mg USD 30  USD30 In stock
5mg USD 40  USD40 In stock
10mg USD 75  USD75 In stock
50mg USD 240  USD240 In stock
100mg USD 360  USD360 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

WYE-354 is a potent and ATP competitive inhibitor of mTOR (IC50 = 5 nM), with significant selectivity over PI3K isofoms (>100-fold). WYE-354 is equally potent against mTORC1 and mTORC2 activities in HEK293 immune complex kinase assays using S6K and Akt as the respective substrate (IC50 <200 nM) and effectively blocks cellular phosphorylation of S6K on T389 and Akt on S473 both in cultures and in a murine xenograft model, resulting in a significant suppression of PC3MM2-derived tumor growth (by 86% on day 7; 50 mg/kg, i.p twice per day) in vivo.

Customer Product Validations & Biological Datas
Source Oncotarget (2015). Figure 1. WYE-354
Method MTS assay
Cell Lines Western blot analysis
Concentrations 1 μM
Incubation Time 24, 48, and 72 h
Results WYE-354 significantly reduced cell viability starting at a 1 μM concentration after a 24 hours exposure, in both studied cell lines
Protocol (for reference only)
Cell Experiment
Cell lines Cell lines of Rat1, HEK293, MDA-MB-361, MDA-MB-468, MDA-MB-231, LNCap, DU145, U87MG, A498, HCT116, and HT29
Preparation method Tumor cell growth assays.
Concentrations 0~100 μ M
Incubation time 3 days
Animal Experiment
Animal models PC3MM2 tumors xenograft in BALB/c nu/nu female mice
Formulation formulated in 5% ethanol, 5% polysorbate 80, 5% polyethylene glycol-400
Dosages a single i.p. injection with 50 mg/kg
Administration i.p.
Chemical Information
Molecular Weight 495.5
Formula C24H29N7O5
CAS Number 1062169-56-5
Solubility (25°C) DMSO 30 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Wahdan-Alaswad RS et al. Mol Cancer Res. Inhibition of mTORC1 kinase activates Smads 1 and 5 but not Smad8 in human prostate cancer cells, mediating cytostatic response to rapamycin.

[2] Yu K et al. Cancer Res. Biochemical, cellular, and in vivo activity of novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin.

Related mTOR Products
RMC-4627 

RMC-4627 is a selective mTORC1 inhibitor that activates 4EBP1 and inhibits tumor growth.

RMC-4529 

RMC-4529 has an IC50 value of 1.0 nM against p-4E-BP1-(T37/46) in mTOR kinase cellular assay.

WYE-687 dihydrochloride 

WYE-687 dihydrochloride is an ATP-competitive mTOR inhibitor with an IC50 of 7 nM.

Rapamycin-d3

Rapamycin-d3

L-Leucine-d10

L-Leucine-d10

  Catalog
Abmole Inhibitor Catalog




Keywords: WYE-354 supplier, mTOR, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.